Synapse Medicine
PrivateLast Round
Series B
Mar 1, 2022
Total Funding Raised
$38.83M
Company Overview
Synapse Medicine is a health tech company that provides a Medication Intelligence SaaS platform for healthcare professionals to ensure proper drug use and prevent medication errors.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, EHR & EMR, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Government Contracts, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synapse Medicine Comparables
Compare Synapse Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Posos | 85% | |
| MDI Health | 77% | |
| FeelBetter | 76% |
Synapse Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 1, 2022 | ||||
| Series A | Jul 6, 2020 | ||||
| Seed | Mar 19, 2019 |
Key People
Founding team and executive leadership
Synapse Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korelya Capital | Series B |
| BNP Paribas Développement | Series B |
| XAnge | Series A, Series B, Seed |
| Bpifrance | Series A |
| BNP Paribas | Series A |
| MACSF | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 32% MoM.
- Nov 10, 2025
Monthly visitors increased 76% MoM.
Synapse Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Synapse Medicine's valuation, stock price, and market status.
Is Synapse Medicine a public or private company?
Synapse Medicine is a private company.
What is the current stock price of Synapse Medicine?
Synapse Medicine is a private company with no public stock price. No recent secondary market data is available.
How much is Synapse Medicine worth (valuation)?
Valuation information for Synapse Medicine is not publicly available.
Can I buy Synapse Medicine stock?
Synapse Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Synapse Medicine's last funding round?
Synapse Medicine's most recent funding round was Series B on March 1, 2022.
Who are the main investors in Synapse Medicine?
Key investors in Synapse Medicine include Korelya Capital, XAnge, MACSF.
Will Synapse Medicine IPO soon?
No public IPO plans have been announced for Synapse Medicine.
How can I track Synapse Medicine secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synapse Medicine's secondary market activity and sign up for updates.